Clover Health Investments, Corp.
CLOVFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
1,371
Cost of Revenue
1,006
Gross Profit
365
Gross Margin
26.6%
Operating Income
-46
Operating Margin
-3.3%
Net Income
-43
Net Margin
-3.1%
EPS (Basic)
$-0.09
EPS (Diluted)
$-0.09
EBITDA
-45
EBITDA Margin
-3.3%
2023
12/31/2023
Revenue
1,261
Cost of Revenue
1,005
Gross Profit
256
Gross Margin
20.3%
Operating Income
-205
Operating Margin
-16.3%
Net Income
-213
Net Margin
-16.9%
EPS (Basic)
$-0.45
EPS (Diluted)
$-0.45
EBITDA
-208
EBITDA Margin
-16.5%
2022
12/31/2022
Revenue
1,097
Cost of Revenue
993
Gross Profit
103
Gross Margin
9.4%
Operating Income
-287
Operating Margin
-26.1%
Net Income
-340
Net Margin
-31.0%
EPS (Basic)
$-0.71
EPS (Diluted)
$-0.71
EBITDA
-252
EBITDA Margin
-23.0%
2021
12/31/2021
Revenue
1,472
Cost of Revenue
1,551
Gross Profit
-79
Gross Margin
-5.4%
Operating Income
-637
Operating Margin
-43.3%
Net Income
-588
Net Margin
-39.9%
EPS (Basic)
$-1.25
EPS (Diluted)
$-1.25
EBITDA
-570
EBITDA Margin
-38.7%
2020
12/31/2020
Revenue
673
Cost of Revenue
590
Gross Profit
83
Gross Margin
12.3%
Operating Income
-93
Operating Margin
-13.8%
Net Income
-136
Net Margin
-20.3%
EPS (Basic)
$-0.23
EPS (Diluted)
$-0.23
EBITDA
-79
EBITDA Margin
-11.7%